Protara Therapeutics Inc (TARA)
2.91
+0.02
(+0.69%)
USD |
NASDAQ |
May 03, 16:00
2.89
-0.02
(-0.69%)
After-Hours: 20:00
Protara Therapeutics Enterprise Value: -32.31M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | -32.31M |
| May 02, 2024 | -32.54M |
| May 01, 2024 | -32.08M |
| April 30, 2024 | -31.51M |
| April 29, 2024 | -30.14M |
| April 26, 2024 | -32.14M |
| April 25, 2024 | -30.71M |
| April 24, 2024 | -33.34M |
| April 23, 2024 | -31.28M |
| April 22, 2024 | -30.71M |
| April 19, 2024 | -35.39M |
| April 18, 2024 | -34.14M |
| April 17, 2024 | -34.37M |
| April 16, 2024 | -32.99M |
| April 15, 2024 | -33.11M |
| April 12, 2024 | -31.28M |
| April 11, 2024 | -30.25M |
| April 10, 2024 | -29.11M |
| April 09, 2024 | -28.76M |
| April 08, 2024 | -26.36M |
| April 05, 2024 | -24.08M |
| April 04, 2024 | -19.62M |
| April 03, 2024 | -18.70M |
| April 02, 2024 | -18.59M |
| April 01, 2024 | -18.24M |
| Date | Value |
|---|---|
| March 28, 2024 | -19.73M |
| March 27, 2024 | -19.84M |
| March 26, 2024 | -18.13M |
| March 25, 2024 | -19.96M |
| March 22, 2024 | -19.62M |
| March 21, 2024 | -20.99M |
| March 20, 2024 | -19.50M |
| March 19, 2024 | -19.84M |
| March 18, 2024 | -19.84M |
| March 15, 2024 | -23.50M |
| March 14, 2024 | -24.76M |
| March 13, 2024 | -23.85M |
| March 12, 2024 | -24.76M |
| March 11, 2024 | -24.76M |
| March 08, 2024 | -22.13M |
| March 07, 2024 | -22.05M |
| March 06, 2024 | -20.69M |
| March 05, 2024 | -23.08M |
| March 04, 2024 | -15.57M |
| March 01, 2024 | -13.30M |
| February 29, 2024 | -13.76M |
| February 28, 2024 | -14.78M |
| February 27, 2024 | -10.69M |
| February 26, 2024 | -12.28M |
| February 23, 2024 | -17.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-68.94M
Minimum
Nov 09 2022
319.91M
Maximum
Jun 02 2020
6.285M
Average
-24.76M
Median
Mar 11 2024
Enterprise Value Benchmarks
| AngioDynamics Inc | 172.69M |
| Regulus Therapeutics Inc | 151.06M |
| Bio-Path Holdings Inc | 0.7197M |
| Outset Medical Inc | 85.38M |
| AN2 Therapeutics Inc | -30.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.22M |
| Total Expenses (Quarterly) | 11.04M |
| EPS Diluted (Quarterly) | -0.90 |
| Earnings Yield | -122.7% |